A systematic review of 74 optical studies shows that tolerance to decentration depends on IOL design, especially for aspheric and presbyopia-correcting optics.
doi: 10.1097/j.jcrs.0000000000001950In a prospective 114-eye cohort, both versions produced similar binocular vision from distance to near, while halo burden remained an important limitation.
doi: 10.1155/joph/3788361In a nonrandomized study, EDOF and mix-and-match performed better at intermediate distance, while bifocal and mix-and-match performed better on corrected near testing.
doi: 10.1371/journal.pone.0341136In 85 patients, Vivity provided better uncorrected near and intermediate vision, whereas PureSee produced higher contrast sensitivity and less dysphotopsia.
doi: 10.1111/aos.70076In a masked randomized trial, both strategies produced good distance and intermediate vision, but mini-monovision reduced low-contrast acuity and slightly increased glare.
doi: 10.1016/j.ajo.2026.09.009In a prospective series of 115 eyes, typical angle-kappa and angle-alpha values showed no clinically important association with outcomes of a nondiffractive EDOF IOL at three months.
doi: 10.1186/s12886-026-04993-5A randomized trial compared bilateral EDF and monofocal IOL implantation: the extended-depth design improved intermediate and near vision and more often allowed near tasks without spectacles.
doi: 10.1097/j.jcrs.0000000000001942In a randomized masked study, 40 patients received DEN00V in one eye and AN6V in the fellow eye. Both provided extended vision at three months, while the primary endpoint favored AN6V.
doi: 10.1016/j.ajo.2026.04.014In 92 patients, three EDOF approaches improved uncorrected intermediate and near vision compared with a monofocal lens, while the profile of photic phenomena differed between designs.
doi: 10.1016/j.jfo.2026.104823A randomized study of 70 cataract patients compared PanOptix with Vivity. Stereopsis favored the EDOF group at one month, while contrast sensitivity did not differ significantly between groups.
doi: 10.4103/IJO.IJO_2015_25